Topical Advisory Panel for section 'Pharmacokinetics and Pharmacodynamics'
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please see the section webpage for more information on this section.
Members
Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: pharmacokinetics; pharmacodynamics; pharmacometrics; antibiotics; antivirals
Interests: pharmacokinetics; pharmacodynamics; pharmacometrics; antibiotics; antivirals
Dr. Helena Barrasa
Intensive Care Unit, Araba University Hospital, 01004 Vitoria-Gasteiz, Spain
Interests: PK/PD; augmented renal clearance; CTRR; infection; critical care; linezolid
Interests: PK/PD; augmented renal clearance; CTRR; infection; critical care; linezolid
College of Pharmacy, Woosuk University, Wanju-gun 55338, Republic of Korea
Interests: pharmacokinetics; drug interactions; transrpoters; CYP450 induction; pharmacokinetic alteractions in disease
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacokinetics; drug interactions; transrpoters; CYP450 induction; pharmacokinetic alteractions in disease
Special Issues, Collections and Topics in MDPI journals
Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada
Interests: ABC transporters; drug disposition; drug–drug interactions; drug resistance; excretion; membrane dynamics; organic anion transporters; organic cation transporters; pharmacokinetics; privileged sites of drug action; solute carrier transporters
Special Issues, Collections and Topics in MDPI journals
Interests: ABC transporters; drug disposition; drug–drug interactions; drug resistance; excretion; membrane dynamics; organic anion transporters; organic cation transporters; pharmacokinetics; privileged sites of drug action; solute carrier transporters
Special Issues, Collections and Topics in MDPI journals
Faculty of Pharmacy, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Interests: pharmacokinetics; microdidalysis; antimicrobials; influence of infection on drug's tissue distribution; antimicrobials PK/PD modeling
Interests: pharmacokinetics; microdidalysis; antimicrobials; influence of infection on drug's tissue distribution; antimicrobials PK/PD modeling
Department of Pharmacology and Toxicology, Université de Reims Champagne-Ardenne, HERVI, CHU Reims, 51100 Reims, France
Interests: pharmacology and pharmacokinetic-pharmacodynamic modelling; therapeutic drug monitoring; clinical research methodology
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology and pharmacokinetic-pharmacodynamic modelling; therapeutic drug monitoring; clinical research methodology
Special Issues, Collections and Topics in MDPI journals
Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, 3000 Leuven, Belgium
Interests: pharmacometrics; precision dosing; therapeutic drug monitoring; pharmacokinetics; pharmacodynamics; nonlinear mixed effects modelling; modelling and simulation; infectious diseases; immune-mediated diseases; monoclonal antibodies; antimicrobial drugs
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacometrics; precision dosing; therapeutic drug monitoring; pharmacokinetics; pharmacodynamics; nonlinear mixed effects modelling; modelling and simulation; infectious diseases; immune-mediated diseases; monoclonal antibodies; antimicrobial drugs
Special Issues, Collections and Topics in MDPI journals
Dr. Samit Ganguly
Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN, USA
Interests: clinical pharmacology; pharmacokinetics; drug transport; drug-drug interaction
Interests: clinical pharmacology; pharmacokinetics; drug transport; drug-drug interaction
Department of Medical Sciences II - Pharmacology, Clinical Pharmacology and Algesiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania
Interests: anti-bacterial agents; pharmacokinetics; stress hormones; clinical studies
Special Issues, Collections and Topics in MDPI journals
Interests: anti-bacterial agents; pharmacokinetics; stress hormones; clinical studies
Special Issues, Collections and Topics in MDPI journals
National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS, USA
Interests: pharmacology; pharmacokinetics; natural products; dietary supplement; herb-drug interaction
Interests: pharmacology; pharmacokinetics; natural products; dietary supplement; herb-drug interaction
Dr. Renato Heidor
Laboratory of Diet, Nutrition and Cancer, Department of Food and Experimental Nutrition, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil
Interests: food-drug interactions; hepatology; liver cancer; cancer chemoprevention; molecular pharmacology; toxicology
Interests: food-drug interactions; hepatology; liver cancer; cancer chemoprevention; molecular pharmacology; toxicology
Prof. Dr. Vesna Jacevic
1. Department for Experimental Toxicology and Pharmacology, National Poison Control Centre, Belgrade, Serbia
2. Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia
3. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
Interests: toxicology; pharmacology; toxicological pathology; non-clinical tests; GLP
Special Issues, Collections and Topics in MDPI journals
2. Medical Faculty of the Military Medical Academy, University of Defence, Belgrade, Serbia
3. Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic
Interests: toxicology; pharmacology; toxicological pathology; non-clinical tests; GLP
Special Issues, Collections and Topics in MDPI journals
Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA
Interests: drug metabolism and pharmacokinetics (DMPK); LC-MS/MS; bioanalysis; quantitative proteomics; NAFLD
Interests: drug metabolism and pharmacokinetics (DMPK); LC-MS/MS; bioanalysis; quantitative proteomics; NAFLD
Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, 14 Św. Marii Magdaleny Str., 61-861 Poznan, Poland
Interests: pharmacokinetics; drug-drug interaction; tyrosine kinase inhibitor; blood-brain barrier
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacokinetics; drug-drug interaction; tyrosine kinase inhibitor; blood-brain barrier
Special Issues, Collections and Topics in MDPI journals
Dr. Tony K. L. Kiang
Faculty of Pharmacy and Pharmaceutical Sciences, The University of Alberta, Edmonton, AB, Canada
Interests: pharmacokinetics; toxicology; uremic toxins; pharmacogenomics; drug metabolism; population pharmacokinetic modeling
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacokinetics; toxicology; uremic toxins; pharmacogenomics; drug metabolism; population pharmacokinetic modeling
Special Issues, Collections and Topics in MDPI journals
Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland
Interests: transporters; permeability; blood-brain barrier; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: transporters; permeability; blood-brain barrier; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Department of Pharmaceutical Engineering, Inje University, Gimhae 50834, Republic of Korea
Interests: pharmacokinetics; drug metabolism; drug–drug interaction; PK/PD; modeling and simulation; PBPK; data analysis
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacokinetics; drug metabolism; drug–drug interaction; PK/PD; modeling and simulation; PBPK; data analysis
Special Issues, Collections and Topics in MDPI journals
Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia
Interests: antimicrobial pharmacokinetics/pharmacodynamics; pharmacokinetic modeling; antibiotic combination; drug delivery; dose optimization
Interests: antimicrobial pharmacokinetics/pharmacodynamics; pharmacokinetic modeling; antibiotic combination; drug delivery; dose optimization
Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Republic of Korea
Interests: pharmacokinetics; physiologically based pharmacokinetic (PBPK) modeling and simulation; pharmacokinetic–pharmacodynamic (PK-PD) modeling and simulation; drug–drug interaction (DDI); in vitro–in vivo extrapolation (IVIVE)
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacokinetics; physiologically based pharmacokinetic (PBPK) modeling and simulation; pharmacokinetic–pharmacodynamic (PK-PD) modeling and simulation; drug–drug interaction (DDI); in vitro–in vivo extrapolation (IVIVE)
Special Issues, Collections and Topics in MDPI journals
Dr. Jong Hwa Lee
Bioanalysis and Pharmacokinetic Research Group, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea
Interests: toxico-/pharmacokinetics; bioanalysis; ADME; metabolism; method validation
Special Issues, Collections and Topics in MDPI journals
Interests: toxico-/pharmacokinetics; bioanalysis; ADME; metabolism; method validation
Special Issues, Collections and Topics in MDPI journals
Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA
Interests: drug repurposing; AI; toxicology; bioifnromatics
Interests: drug repurposing; AI; toxicology; bioifnromatics
Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12800 Prague, Czech Republic
Interests: population pharmacokinetics; optimization of dosing regimens; multiple sclerosis; inflammation; oxidative stress
Interests: population pharmacokinetics; optimization of dosing regimens; multiple sclerosis; inflammation; oxidative stress
Dept. of Clinical Pharmacy & Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169 Berlin, Germany
Interests: model-based precision dosing; pharmacometrics; translational research; nonlinear mixed-effects modelling; physiologically based pharmacokinetic modelling
Special Issues, Collections and Topics in MDPI journals
Interests: model-based precision dosing; pharmacometrics; translational research; nonlinear mixed-effects modelling; physiologically based pharmacokinetic modelling
Special Issues, Collections and Topics in MDPI journals
Dr. Keumhan Noh
Drug Metabolism and Pharmacokinetics, Biogen, 225 Binney Street, Cambridge, MA 02142, USA
Interests: PKPD modeling; drug-drug interaction; human dose projection; IVIVC
Special Issues, Collections and Topics in MDPI journals
Interests: PKPD modeling; drug-drug interaction; human dose projection; IVIVC
Special Issues, Collections and Topics in MDPI journals
Dr. Angelo Paci
Service de Pharmacologie, Gustave Roussy Cancer center, Villejuif, France & Faculté de Pharmacie, Université Paris-Saclay, Chatenay-Malabry, France
Interests: pharmacology; oncology; pharmacokinetics; nanomedicines
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacology; oncology; pharmacokinetics; nanomedicines
Special Issues, Collections and Topics in MDPI journals
1. Department of Pharmaceutical Sciences, University of Salamanca, Pharmacy Faculty, Campus Miguel de Unamuno, 37007 Salamanca, Spain
2. Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Hospital Virgen de la Vega, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain
Interests: pharmacometrics (PMX); population pharmacokinetics (PopPK); pharmacokinetics-pharmacodynamics (PKPD); model-informed precision dosing (MIPD); modeling and simulation (M&S)
Special Issues, Collections and Topics in MDPI journals
2. Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Hospital Virgen de la Vega, Paseo de San Vicente, 58-182, 37007 Salamanca, Spain
Interests: pharmacometrics (PMX); population pharmacokinetics (PopPK); pharmacokinetics-pharmacodynamics (PKPD); model-informed precision dosing (MIPD); modeling and simulation (M&S)
Special Issues, Collections and Topics in MDPI journals
Cell Biology, Neurobiology and Biophysics, Department of Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands
Interests: cancer biology; cancer chemotherapy; microtubule dynamics; microtubule targeting drugs; single-molecule analysis; pharmaceutical kinetics; drug discovery
Interests: cancer biology; cancer chemotherapy; microtubule dynamics; microtubule targeting drugs; single-molecule analysis; pharmaceutical kinetics; drug discovery
Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia
Interests: QSAR; molecular dynamics; pharmacokinetic interactions; drug metabolism
Special Issues, Collections and Topics in MDPI journals
Interests: QSAR; molecular dynamics; pharmacokinetic interactions; drug metabolism
Special Issues, Collections and Topics in MDPI journals
SMARTc, CRCM, Inserm UMR1068, CNRS UMR7258, Aix Marseille Université U105, Institut Paoli Calmettes, Marseille, France
Interests: nanomedicine; pharmacokinetics; oncology; drug delivery; oncopharmacology; PK/PD modeling; PBPK
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; pharmacokinetics; oncology; drug delivery; oncopharmacology; PK/PD modeling; PBPK
Special Issues, Collections and Topics in MDPI journals
Mathematical institute, Leiden University, Leiden, The Netherlands
Interests: mathematical models; differential equations; analysis of models; pharmacokinetics-pharmacodynamics (PKPD) model
Interests: mathematical models; differential equations; analysis of models; pharmacokinetics-pharmacodynamics (PKPD) model
